Bravo, Francisca Vaz
Da Silva, Jorge
Chan, Robin Barry
Di Paolo, Gilbert
Teixeira-Castro, Andreia
Oliveira, Tiago Gil http://orcid.org/0000-0003-0509-0562
Article History
Received: 7 September 2017
Accepted: 13 February 2018
First Online: 23 February 2018
Competing Interests
: G.D.P. is a full time employee of Denali Therapeutics Inc. G.D.P. and T.G.O. are inventors on the patent number WO2010138869A1 entitled “Modulation of phospholipase D for the treatment of neurodegene-rative disorders”. R.B.C., G.D.P. and T.G.O. are inventors on the patent number US20120302604A1 entitled “Modulation of phospholipase D for the treatment of the acute and chronic effects of ethanol”.